Cargando…
Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
OBJECTIVE: To investigate dopaminergic function in a large cohort of patients with corticobasal syndrome (CBS) and describe its relationship with clinical features in comparison to Parkinson's disease and healthy control subjects. In addition, we assessed prevalence and features of individuals...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085517/ https://www.ncbi.nlm.nih.gov/pubmed/21559307 http://dx.doi.org/10.1371/journal.pone.0018301 |
_version_ | 1782202643300483072 |
---|---|
author | Cilia, Roberto Rossi, Carlo Frosini, Daniela Volterrani, Duccio Siri, Chiara Pagni, Cristina Benti, Riccardo Pezzoli, Gianni Bonuccelli, Ubaldo Antonini, Angelo Ceravolo, Roberto |
author_facet | Cilia, Roberto Rossi, Carlo Frosini, Daniela Volterrani, Duccio Siri, Chiara Pagni, Cristina Benti, Riccardo Pezzoli, Gianni Bonuccelli, Ubaldo Antonini, Angelo Ceravolo, Roberto |
author_sort | Cilia, Roberto |
collection | PubMed |
description | OBJECTIVE: To investigate dopaminergic function in a large cohort of patients with corticobasal syndrome (CBS) and describe its relationship with clinical features in comparison to Parkinson's disease and healthy control subjects. In addition, we assessed prevalence and features of individuals with CBS and in vivo evidence of preserved nigral neuronal density. BACKGROUND: Substantia nigra pars compacta (SNc) neuronal degeneration is a mandatory pathological criterion for definite corticobasal degeneration, though sporadic autopsy-proven cases with ante-mortem imaging evidence of preserved nigral terminals have been recently described. METHODS: In this multicenter study, we investigated presynaptic nigrostriatal function in 36 outpatients fulfilling clinical criteria for “probable corticobasal degeneration” (age 71±7.3 years; disease duration 3.9±1.6 years), 37 PD and 24 healthy control subjects using FP-CIT single photon emission computed tomography. Clinical, neuropsychological, and magnetic resonance imaging assessment was performed to characterize CBS patients. Linear discriminant analysis was used to categorize normal vs. pathological scans. RESULTS: FP-CIT binding reduction in patients with CBS was characterized by larger variability, more uniform reduction throughout the striatum and greater hemispheric asymmetry compared to PD. Moreover, there was no significant correlation between tracer uptake values and clinical features such as disease duration and severity. Despite all CBS subjects showed obvious bilateral extrapyramidal signs, FP-CIT uptake was found to be normal bilaterally in four CBS patients and only unilaterally in other four cases. Extensive clinical, neuropsychological and imaging assessment did not reveal remarkable differences between CBS subjects with normal vs. pathological FP-CIT uptake. CONCLUSIONS: Our findings support the hypothesis that extrapyramidal motor symptoms in CBS are not invariably associated with SNc neuronal degeneration and that supranigral factors may play a major role in several cases. CBS individuals with normal FP-CIT uptake do not show any clinical or cognitive feature suggesting a different pathology than CBD. |
format | Text |
id | pubmed-3085517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30855172011-05-10 Dopamine Transporter SPECT Imaging in Corticobasal Syndrome Cilia, Roberto Rossi, Carlo Frosini, Daniela Volterrani, Duccio Siri, Chiara Pagni, Cristina Benti, Riccardo Pezzoli, Gianni Bonuccelli, Ubaldo Antonini, Angelo Ceravolo, Roberto PLoS One Research Article OBJECTIVE: To investigate dopaminergic function in a large cohort of patients with corticobasal syndrome (CBS) and describe its relationship with clinical features in comparison to Parkinson's disease and healthy control subjects. In addition, we assessed prevalence and features of individuals with CBS and in vivo evidence of preserved nigral neuronal density. BACKGROUND: Substantia nigra pars compacta (SNc) neuronal degeneration is a mandatory pathological criterion for definite corticobasal degeneration, though sporadic autopsy-proven cases with ante-mortem imaging evidence of preserved nigral terminals have been recently described. METHODS: In this multicenter study, we investigated presynaptic nigrostriatal function in 36 outpatients fulfilling clinical criteria for “probable corticobasal degeneration” (age 71±7.3 years; disease duration 3.9±1.6 years), 37 PD and 24 healthy control subjects using FP-CIT single photon emission computed tomography. Clinical, neuropsychological, and magnetic resonance imaging assessment was performed to characterize CBS patients. Linear discriminant analysis was used to categorize normal vs. pathological scans. RESULTS: FP-CIT binding reduction in patients with CBS was characterized by larger variability, more uniform reduction throughout the striatum and greater hemispheric asymmetry compared to PD. Moreover, there was no significant correlation between tracer uptake values and clinical features such as disease duration and severity. Despite all CBS subjects showed obvious bilateral extrapyramidal signs, FP-CIT uptake was found to be normal bilaterally in four CBS patients and only unilaterally in other four cases. Extensive clinical, neuropsychological and imaging assessment did not reveal remarkable differences between CBS subjects with normal vs. pathological FP-CIT uptake. CONCLUSIONS: Our findings support the hypothesis that extrapyramidal motor symptoms in CBS are not invariably associated with SNc neuronal degeneration and that supranigral factors may play a major role in several cases. CBS individuals with normal FP-CIT uptake do not show any clinical or cognitive feature suggesting a different pathology than CBD. Public Library of Science 2011-05-02 /pmc/articles/PMC3085517/ /pubmed/21559307 http://dx.doi.org/10.1371/journal.pone.0018301 Text en Cilia et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Cilia, Roberto Rossi, Carlo Frosini, Daniela Volterrani, Duccio Siri, Chiara Pagni, Cristina Benti, Riccardo Pezzoli, Gianni Bonuccelli, Ubaldo Antonini, Angelo Ceravolo, Roberto Dopamine Transporter SPECT Imaging in Corticobasal Syndrome |
title | Dopamine Transporter SPECT Imaging in Corticobasal Syndrome |
title_full | Dopamine Transporter SPECT Imaging in Corticobasal Syndrome |
title_fullStr | Dopamine Transporter SPECT Imaging in Corticobasal Syndrome |
title_full_unstemmed | Dopamine Transporter SPECT Imaging in Corticobasal Syndrome |
title_short | Dopamine Transporter SPECT Imaging in Corticobasal Syndrome |
title_sort | dopamine transporter spect imaging in corticobasal syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085517/ https://www.ncbi.nlm.nih.gov/pubmed/21559307 http://dx.doi.org/10.1371/journal.pone.0018301 |
work_keys_str_mv | AT ciliaroberto dopaminetransporterspectimagingincorticobasalsyndrome AT rossicarlo dopaminetransporterspectimagingincorticobasalsyndrome AT frosinidaniela dopaminetransporterspectimagingincorticobasalsyndrome AT volterraniduccio dopaminetransporterspectimagingincorticobasalsyndrome AT sirichiara dopaminetransporterspectimagingincorticobasalsyndrome AT pagnicristina dopaminetransporterspectimagingincorticobasalsyndrome AT bentiriccardo dopaminetransporterspectimagingincorticobasalsyndrome AT pezzoligianni dopaminetransporterspectimagingincorticobasalsyndrome AT bonuccelliubaldo dopaminetransporterspectimagingincorticobasalsyndrome AT antoniniangelo dopaminetransporterspectimagingincorticobasalsyndrome AT ceravoloroberto dopaminetransporterspectimagingincorticobasalsyndrome |